肿瘤模型Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models.
期刊:Molecular cancer therapeutics发表年份:2012作者:Caroline C Clark; Jeffrey N Weitzel; Timothy R O'Connor
